Literature DB >> 10068382

Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.

R S Sandler1, N L Zorich, T G Filloon, H B Wiseman, D J Lietz, M H Brock, M G Royer, R K Miday.   

Abstract

BACKGROUND: Olestra is a nonabsorbable, energy-free fat substitute. Because it is not absorbed, it may cause digestive symptoms when consumed in large amounts.
OBJECTIVE: To compare the frequency and impact of gastrointestinal symptoms in adults and children who freely consume snacks containing olestra or regular snacks in the home.
DESIGN: 6-week, double-blind, randomized, parallel, placebo-controlled trial.
SETTING: General community. PARTICIPANTS: 3181 volunteers 2 to 89 years of age. INTERVENTION: Households received identical packages labeled as containing olestra corn or potato chips. These packages contained either olestra or regular chips (control). MEASUREMENT: Gastrointestinal symptoms and their impact on daily activities were reported in a daily record.
RESULTS: At least one gastrointestinal symptom was reported by 619 of 1620 (38.2%) persons in the olestra group and 576 of 1561 (36.9%) controls (difference, 1.3 percentage points [95% CI, -3.6 to 6.2 percentage points]; P = 0.60). In general, the groups did not differ significantly in the proportion of participants who reported individual gastrointestinal symptoms; however, more controls reported nausea (8.4% compared with 5.7%; difference, -2.7 percentage points [CI, -4.9 to -0.4 percentage points]; P = 0.02). The only difference between groups for the mean numbers of days on which symptoms were reported was that participants in the olestra group had 1 more symptom-day of more frequent bowel movements than did controls (3.7 symptom-days compared with 2.8 symptom days; difference, 0.9 symptom-days [CI, 0.1 to 1.8 symptom-days]; P = 0.04). The groups did not differ in the impact of symptoms on daily activities.
CONCLUSIONS: Clinically meaningful or bothersome gastrointestinal effects are not associated with unregulated consumption of olestra corn and potato chips in the home.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068382     DOI: 10.7326/0003-4819-130-4_part_1-199902160-00002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.

Authors:  Jane Levine; Joan Dye Gussow; Diane Hastings; Amy Eccher
Journal:  Am J Public Health       Date:  2003-04       Impact factor: 9.308

Review 2.  Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Authors:  Dean Fergusson; Kathleen Cranley Glass; Duff Waring; Stan Shapiro
Journal:  BMJ       Date:  2004-01-22

3.  Perceptions of flatulence from bean consumption among adults in 3 feeding studies.

Authors:  Donna M Winham; Andrea M Hutchins
Journal:  Nutr J       Date:  2011-11-21       Impact factor: 3.271

Review 4.  An assessment of the intestinal lumen as a site for intervention in reducing body burdens of organochlorine compounds.

Authors:  Ronald J Jandacek; Stephen J Genuis
Journal:  ScientificWorldJournal       Date:  2013-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.